Skip to main content
Back to CRV

CRV's Biotechnology Portfolio

Browse 8 Biotechnology companies funded by CRV. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
8
Total Funding in Biotechnology
$378.1M

Biotechnology Portfolio Companies (8)

Export
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

Menlo Park, United States
August 2022
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

San Francisco, United States
December 2022
$10.0M
Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine Learning

Valinor Discovery uses machine learning to simulate drug performance and support data-driven drug development decisions.

San Francisco, United States
December 2025
$13.0M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Exo Therapeutics is a small molecule drug discovery and development company.

Cambridge, United States
October 2021
$78.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth Care

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

Cambridge, United States
May 2021
$100.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyNeuroscienceTherapeutics

System1 Biosciences is a neurotherapeutics company.

San Francisco, United States
September 2018
$25.0M
Series A

Founder Contacts

41,000+ verified contacts

Explore CRV's Full Portfolio

View all companies funded by CRV across every industry and funding stage.

View Full CRV Portfolio